Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.1.1.4 extracted from

  • Phillips, R.M.; Six, D.A.; Dennis, E.A.; Ghosh, P.
    In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors (2003), J. Biol. Chem., 278, 41326-41332.
    View publication on PubMed

Cloned(Commentary)

Cloned (Comment) Organism
-
Pseudomonas aeruginosa

Inhibitors

Inhibitors Comment Organism Structure
additional information phospholipase A2 inhibitors may represent a novel mode of treatment for acute infection of Pseudomonas aeruginosa Pseudomonas aeruginosa

Localization

Localization Comment Organism GeneOntology No. Textmining
plasma membrane ExoU localizes to the host cell plasma membrane in punctate fashion Pseudomonas aeruginosa 5886
-

Organism

Organism UniProt Comment Textmining
Pseudomonas aeruginosa
-
PA103
-
Pseudomonas aeruginosa PA103
-
PA103
-

Purification (Commentary)

Purification (Comment) Organism
-
Pseudomonas aeruginosa

Synonyms

Synonyms Comment Organism
ExoU
-
Pseudomonas aeruginosa

Cofactor

Cofactor Comment Organism Structure
additional information ExoU lacks detectable phospholipase or esterase activity in vitro, experiments in vivo demonstrate significant phospholipase activity, indicating that one or more host cell factors are required for activation of ExoU Pseudomonas aeruginosa